Clinical Trial: Comparison of Pregnancy Outcomes in Primigravida Receiving Low-Dose Aspirin for the Prevention of Preeclampsia.

U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07852585) titled 'Comparison of Pregnancy Outcomes in Primigravida Receiving Low-Dose Aspirin for the Prevention of Preeclampsia.' on Sept. 25.

Brief Summary: Local data on the effectiveness of low-dose aspirin in high-risk primigravida are limited. The present study was planned to compare pregnancy outcomes between high-risk primigravida receiving low-dose aspirin (75 mg/day) from 12 weeks of gestation and those not receiving aspirin.

Study Start Date: Aug. 01, 2025

Study Type: INTERVENTIONAL

Condition: Preeclampsia

Intervention: DRUG: Low-dose aspirin

Participants received low-dose aspirin (75 mg) once daily, starting at 12 weeks of gestation...